Wave Life Sciences (WVE) News Today $8.10 +0.16 (+2.02%) Closing price 05/2/2025 04:00 PM EasternExtended Trading$8.04 -0.05 (-0.68%) As of 04:26 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 Time Period Wave Life Sciences Ltd. (NASDAQ:WVE) Shares Sold by 683 Capital Management LLC683 Capital Management LLC lowered its position in Wave Life Sciences Ltd. (NASDAQ:WVE - Free Report) by 9.9% during the fourth quarter, according to its most recent filing with the SEC. The institutional investor owned 3,785,000 shares of the company's stock after selling 415,000 shares during thMay 4 at 7:13 AM | marketbeat.comResearch Analysts Offer Predictions for WVE FY2026 EarningsWave Life Sciences Ltd. (NASDAQ:WVE - Free Report) - Equities researchers at Leerink Partnrs boosted their FY2026 EPS estimates for shares of Wave Life Sciences in a note issued to investors on Tuesday, April 29th. Leerink Partnrs analyst J. Schwartz now expects that the company will post earningMay 3 at 8:53 AM | marketbeat.comCantor Fitzgerald Predicts WVE FY2025 EarningsWave Life Sciences Ltd. (NASDAQ:WVE - Free Report) - Stock analysts at Cantor Fitzgerald issued their FY2025 earnings estimates for shares of Wave Life Sciences in a report issued on Tuesday, April 29th. Cantor Fitzgerald analyst S. Seedhouse anticipates that the company will post earnings of ($1May 3 at 7:45 AM | marketbeat.comAquatic Capital Management LLC Takes Position in Wave Life Sciences Ltd. (NASDAQ:WVE)Aquatic Capital Management LLC acquired a new position in shares of Wave Life Sciences Ltd. (NASDAQ:WVE - Free Report) in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 82,018 shares of the company'sMay 3 at 5:10 AM | marketbeat.comWave Life Sciences (WVE) Projected to Post Quarterly Earnings on ThursdayWave Life Sciences (NASDAQ:WVE) will be releasing its Q1 2025 earnings before the market opens on Thursday, May 8. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2025-5-8-wave-life-sciences-ltd-stock/)May 3 at 4:15 AM | marketbeat.comBarclays PLC Purchases 36,312 Shares of Wave Life Sciences Ltd. (NASDAQ:WVE)Barclays PLC lifted its position in shares of Wave Life Sciences Ltd. (NASDAQ:WVE - Free Report) by 22.8% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 195,553 shares of the comMay 3 at 3:39 AM | marketbeat.comCantor Fitzgerald Weighs in on WVE FY2025 EarningsMay 3 at 2:51 AM | americanbankingnews.comLeerink Partnrs Has Bullish Outlook for WVE FY2026 EarningsMay 2 at 4:09 AM | americanbankingnews.comWave Life Sciences (NASDAQ:WVE) Research Coverage Started at Cantor FitzgeraldMay 2 at 2:33 AM | americanbankingnews.comWave Life Sciences (NASDAQ:WVE) Trading Up 4.5% - What's Next?Wave Life Sciences (NASDAQ:WVE) Shares Up 4.5% - Here's What HappenedMay 1, 2025 | marketbeat.comWave Life Sciences (NASDAQ:WVE) Coverage Initiated at Cantor FitzgeraldCantor Fitzgerald began coverage on shares of Wave Life Sciences in a report on Tuesday. They set an "overweight" rating and a $10.00 price target on the stock.May 1, 2025 | marketbeat.comWave Life Sciences First Quarter 2025 Financial Results Scheduled for May 8, 2025May 1, 2025 | globenewswire.comPrice T Rowe Associates Inc. MD Grows Stock Holdings in Wave Life Sciences Ltd. (NASDAQ:WVE)Price T Rowe Associates Inc. MD increased its stake in shares of Wave Life Sciences Ltd. (NASDAQ:WVE - Free Report) by 63.1% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 5,098,866 shares of the companMay 1, 2025 | marketbeat.comCantor Fitzgerald sets WAVE Life Sciences stock at OverweightApril 30, 2025 | uk.investing.comEmerald Mutual Fund Advisers Trust Has $23.89 Million Holdings in Wave Life Sciences Ltd. (NASDAQ:WVE)Emerald Mutual Fund Advisers Trust lowered its position in Wave Life Sciences Ltd. (NASDAQ:WVE - Free Report) by 9.1% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 1,931,034 shares of the company's stock after selling 192,April 30, 2025 | marketbeat.com5WVE : The Analyst Verdict: WAVE Life Sciences In The Eyes Of 4 ExpertsApril 29, 2025 | benzinga.comCantor Fitzgerald Initiates Coverage of Wave Life Sciences (WVE) with Overweight RecommendationApril 29, 2025 | msn.comMarshall Wace LLP Purchases 55,325 Shares of Wave Life Sciences Ltd. (NASDAQ:WVE)Marshall Wace LLP increased its position in shares of Wave Life Sciences Ltd. (NASDAQ:WVE - Free Report) by 43.0% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 183,875 shares of the company's stock after acquiring an additApril 29, 2025 | marketbeat.comRussell Investments Group Ltd. Purchases 43,398 Shares of Wave Life Sciences Ltd. (NASDAQ:WVE)Russell Investments Group Ltd. grew its holdings in shares of Wave Life Sciences Ltd. (NASDAQ:WVE - Free Report) by 3,471.8% in the 4th quarter, according to its most recent disclosure with the SEC. The fund owned 44,648 shares of the company's stock after purchasing an additional 43,398 shares durApril 26, 2025 | marketbeat.comAdage Capital Partners GP L.L.C. Has $119.03 Million Stock Holdings in Wave Life Sciences Ltd. (NASDAQ:WVE)Adage Capital Partners GP L.L.C. trimmed its holdings in shares of Wave Life Sciences Ltd. (NASDAQ:WVE - Free Report) by 0.8% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 9,622,104 shares of the company's stock after selApril 25, 2025 | marketbeat.comWave Life Sciences Ltd. (NASDAQ:WVE) Receives $22.18 Consensus Target Price from AnalystsApril 25, 2025 | americanbankingnews.comWave Life Sciences (NASDAQ:WVE) Shares Up 10.7% - Still a Buy?Wave Life Sciences (NASDAQ:WVE) Shares Up 10.7% - Time to Buy?April 23, 2025 | marketbeat.comWave Life Sciences Ltd. (NASDAQ:WVE) Given Consensus Rating of "Buy" by BrokeragesShares of Wave Life Sciences Ltd. (NASDAQ:WVE - Get Free Report) have been assigned an average rating of "Buy" from the eleven ratings firms that are currently covering the firm, Marketbeat Ratings reports. One research analyst has rated the stock with a hold rating, nine have issued a buy ratingApril 23, 2025 | marketbeat.comM28 Capital Management LP Sells 500,000 Shares of Wave Life Sciences Ltd. (NASDAQ:WVE)M28 Capital Management LP decreased its position in Wave Life Sciences Ltd. (NASDAQ:WVE - Free Report) by 8.1% in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 5,664,548 shares of the company's stock after selling 500,000 shares dApril 22, 2025 | marketbeat.comJump Financial LLC Makes New Investment in Wave Life Sciences Ltd. (NASDAQ:WVE)Jump Financial LLC purchased a new position in shares of Wave Life Sciences Ltd. (NASDAQ:WVE - Free Report) during the fourth quarter, according to its most recent 13F filing with the SEC. The institutional investor purchased 123,707 shares of the company's stock, valued at approximately $1,530,00April 22, 2025 | marketbeat.comWave Life Sciences Ltd. (NASDAQ:WVE) Short Interest UpdateWave Life Sciences Ltd. (NASDAQ:WVE - Get Free Report) was the recipient of a significant increase in short interest in March. As of March 31st, there was short interest totalling 9,940,000 shares, an increase of 19.2% from the March 15th total of 8,340,000 shares. Approximately 9.2% of the company's stock are sold short. Based on an average trading volume of 1,150,000 shares, the days-to-cover ratio is currently 8.6 days.April 22, 2025 | marketbeat.comFranklin Resources Inc. Trims Stock Position in Wave Life Sciences Ltd. (NASDAQ:WVE)Franklin Resources Inc. trimmed its holdings in Wave Life Sciences Ltd. (NASDAQ:WVE - Free Report) by 54.3% during the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 42,526 shares of the company's stock after selling 50,570 shares during the quApril 20, 2025 | marketbeat.comEAM Investors LLC Purchases Shares of 214,717 Wave Life Sciences Ltd. (NASDAQ:WVE)EAM Investors LLC bought a new stake in Wave Life Sciences Ltd. (NASDAQ:WVE - Free Report) in the 4th quarter, according to its most recent 13F filing with the SEC. The firm bought 214,717 shares of the company's stock, valued at approximately $2,656,000. EAM Investors LLC owned 0.14% of Wave LifeApril 19, 2025 | marketbeat.comWave Life Sciences Ltd. (NASDAQ:WVE) Holdings Raised by Geode Capital Management LLCGeode Capital Management LLC increased its stake in Wave Life Sciences Ltd. (NASDAQ:WVE - Free Report) by 8.9% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 2,470,751 shares of the company's stock afApril 19, 2025 | marketbeat.comWave Life Sciences Ltd. (NASDAQ:WVE) Stake Lowered by Walleye Capital LLCWalleye Capital LLC trimmed its position in shares of Wave Life Sciences Ltd. (NASDAQ:WVE - Free Report) by 12.6% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 526,698 shares of the compApril 18, 2025 | marketbeat.comFederated Hermes Inc. Invests $841,000 in Wave Life Sciences Ltd. (NASDAQ:WVE)Federated Hermes Inc. bought a new stake in Wave Life Sciences Ltd. (NASDAQ:WVE - Free Report) during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm bought 68,020 shares of the company's stock, valued at approximatelyApril 18, 2025 | marketbeat.comWave Life Sciences (NASDAQ:WVE) Trading 5.4% Higher - Still a Buy?Wave Life Sciences (NASDAQ:WVE) Trading 5.4% Higher - Here's WhyApril 17, 2025 | marketbeat.comWave Life Sciences Ltd. (NASDAQ:WVE) Shares Acquired by Affinity Asset Advisors LLCAffinity Asset Advisors LLC increased its position in shares of Wave Life Sciences Ltd. (NASDAQ:WVE - Free Report) by 7.1% in the 4th quarter, according to the company in its most recent disclosure with the SEC. The fund owned 1,500,000 shares of the company's stock after purchasing an additional 1April 17, 2025 | marketbeat.comMartingale Asset Management L P Decreases Position in Wave Life Sciences Ltd. (NASDAQ:WVE)Martingale Asset Management L P trimmed its holdings in shares of Wave Life Sciences Ltd. (NASDAQ:WVE - Free Report) by 90.7% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 10,300 shares of the companyApril 17, 2025 | marketbeat.comResearch Analysts Issue Forecasts for WVE FY2026 EarningsWave Life Sciences Ltd. (NASDAQ:WVE - Free Report) - Equities researchers at B. Riley dropped their FY2026 earnings per share estimates for shares of Wave Life Sciences in a research report issued to clients and investors on Thursday, April 10th. B. Riley analyst M. El-Saadi now anticipates thatApril 15, 2025 | marketbeat.comNorges Bank Invests $1.24 Million in Wave Life Sciences Ltd. (NASDAQ:WVE)Norges Bank acquired a new position in Wave Life Sciences Ltd. (NASDAQ:WVE - Free Report) in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor acquired 100,000 shares of the company's stock, valued at approximately $1,2April 14, 2025 | marketbeat.comVanguard Group Inc. Raises Stock Position in Wave Life Sciences Ltd. (NASDAQ:WVE)Vanguard Group Inc. increased its stake in shares of Wave Life Sciences Ltd. (NASDAQ:WVE - Free Report) by 10.2% in the fourth quarter, according to its most recent 13F filing with the SEC. The firm owned 3,182,512 shares of the company's stock after purchasing an additional 294,956 shares during tApril 14, 2025 | marketbeat.comWhat is Wedbush's Forecast for WVE Q1 Earnings?Wave Life Sciences Ltd. (NASDAQ:WVE - Free Report) - Equities researchers at Wedbush issued their Q1 2025 earnings estimates for shares of Wave Life Sciences in a research report issued to clients and investors on Tuesday, April 8th. Wedbush analyst Y. Zhong anticipates that the company will earnApril 13, 2025 | marketbeat.comF M Investments LLC Takes Position in Wave Life Sciences Ltd. (NASDAQ:WVE)F M Investments LLC bought a new position in shares of Wave Life Sciences Ltd. (NASDAQ:WVE - Free Report) during the 4th quarter, according to its most recent disclosure with the SEC. The institutional investor bought 226,034 shares of the company's stock, valued at approximately $2,796,000. F M IApril 13, 2025 | marketbeat.comWave Life Sciences price target lowered to $19 from $22 at B. RileyApril 11, 2025 | markets.businessinsider.comWave Life Sciences (NASDAQ:WVE) Now Covered by Analysts at WedbushWedbush initiated coverage on Wave Life Sciences in a report on Tuesday. They set an "outperform" rating and a $18.00 price objective on the stock.April 10, 2025 | marketbeat.comWedbush starts RNA-focused standout Wave Life Sciences with an OutperformApril 8, 2025 | markets.businessinsider.comTrexquant Investment LP Has $5.44 Million Stock Holdings in Wave Life Sciences Ltd. (NASDAQ:WVE)Trexquant Investment LP raised its stake in shares of Wave Life Sciences Ltd. (NASDAQ:WVE - Free Report) by 52.1% in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 439,352 shares of the company's stock after buying an additiApril 7, 2025 | marketbeat.comCinctive Capital Management LP Lowers Position in Wave Life Sciences Ltd. (NASDAQ:WVE)Cinctive Capital Management LP trimmed its position in shares of Wave Life Sciences Ltd. (NASDAQ:WVE - Free Report) by 46.1% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 191,963 shares of the company's stock after sApril 5, 2025 | marketbeat.comWave Life Sciences (NASDAQ:WVE) Trading Down 2.8% - What's Next?Wave Life Sciences (NASDAQ:WVE) Stock Price Down 2.8% - Time to Sell?April 4, 2025 | marketbeat.comWave Life Sciences (NASDAQ:WVE) Shares Gap Down - What's Next?Wave Life Sciences (NASDAQ:WVE) Shares Gap Down - Here's What HappenedApril 3, 2025 | marketbeat.comAnalysts Offer Insights on Healthcare Companies: Wave Life Sciences (WVE) and Nuvation Bio (NUVB)April 2, 2025 | markets.businessinsider.comWhat is Leerink Partnrs' Estimate for WVE Q1 Earnings?Wave Life Sciences Ltd. (NASDAQ:WVE - Free Report) - Equities researchers at Leerink Partnrs issued their Q1 2025 earnings estimates for shares of Wave Life Sciences in a research report issued on Wednesday, March 26th. Leerink Partnrs analyst J. Schwartz expects that the company will post earninMarch 31, 2025 | marketbeat.comLoomis Sayles & Co. L P Takes $20.55 Million Position in Wave Life Sciences Ltd. (NASDAQ:WVE)Loomis Sayles & Co. L P acquired a new stake in Wave Life Sciences Ltd. (NASDAQ:WVE - Free Report) during the fourth quarter, according to its most recent filing with the SEC. The firm acquired 1,660,866 shares of the company's stock, valued at approximately $20,545,000. Loomis Sayles & Co. L P ownMarch 30, 2025 | marketbeat.comArtisan Partners Limited Partnership Trims Holdings in Wave Life Sciences Ltd. (NASDAQ:WVE)Artisan Partners Limited Partnership lowered its position in Wave Life Sciences Ltd. (NASDAQ:WVE - Free Report) by 2.7% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 1,906,790 shares of the company's sMarch 30, 2025 | marketbeat.com Get Wave Life Sciences News Delivered to You Automatically Sign up to receive the latest news and ratings for WVE and its competitors with MarketBeat's FREE daily newsletter. Email Address WVE Media Mentions By Week WVE Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. WVE News Sentiment▼0.860.73▲Average Medical News Sentiment WVE News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. WVE Articles This Week▼256▲WVE Articles Average Week Get Wave Life Sciences News Delivered to You Automatically Sign up to receive the latest news and ratings for WVE and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies RYTM News PTCT News RNA News ZLAB News RARE News ACLX News SWTX News AKRO News OGN News MRUS News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:WVE) was last updated on 5/5/2025 by MarketBeat.com Staff From Our PartnersElon’s Terrifying Warning Forces Trump To Take ActionElon Musk has avoided two major financial crises before. He pulled Tesla and SpaceX back from the brink of col...American Hartford Gold | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredTrump’s Bitcoin Reserve is No Accident…Bryce Paul believes this is the #1 coin to buy right now The catalyst behind this surge is a massive new b...Crypto 101 Media | SponsoredShocking AI play that’s beats Nvidia by a country mileYou’ve seen the headlines about Nvidia. Now Tim Sykes is sounding the alarm — because what CEO Jensen Huang is...Timothy Sykes | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredDonald Trump is about to free crypto from its chains …Sure enough, Bitcoin took off on the exact day Juan said it would. It's up more than 40% since the election...Weiss Ratings | SponsoredElon Set to Shock the World on June 1st?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredGold Alert: The Truth About Fort Knox Is ComingOwning physical gold isn’t the best way to profit. I’ve found a better way to invest in gold—one that’s alr...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Wave Life Sciences Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share Wave Life Sciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.